Xiang J - Search Results

1

Intratumoral coinjection of two adenoviral vectors expressing functional interleukin-18 and inducible protein-10, respectively, synergizes to facilitate regression of established tumors.

Liu Y, Huang H, Saxena A, Xiang J. Liu Y, et al. Among authors: xiang j. Cancer Gene Ther. 2002 Jun;9(6):533-42. doi: 10.1038/sj.cgt.7700466. Cancer Gene Ther. 2002. PMID: 12032664

2

Adenovirus-mediated CD40 ligand gene-engineered dendritic cells elicit enhanced CD8(+) cytotoxic T-cell activation and antitumor immunity.

Liu Y, Zhang X, Zhang W, Chen Z, Chan T, Ali K, Jia Z, Xiang J. Liu Y, et al. Among authors: xiang j. Cancer Gene Ther. 2002 Feb;9(2):202-8. doi: 10.1038/sj.cgt.7700429. Cancer Gene Ther. 2002. PMID: 11857039

3

Antitumor immune responses derived from transgenic expression of CD40 ligand in myeloma cells.

Liu Y, Qureshi M, Xiang J. Liu Y, et al. Among authors: xiang j. Cancer Biother Radiopharm. 2002 Feb;17(1):11-8. doi: 10.1089/10849780252824028. Cancer Biother Radiopharm. 2002. PMID: 11915168

4

Synergistic enhancement of antitumor immunity with adoptively transferred tumor-specific CD4+ and CD8+ T cells and intratumoral lymphotactin transgene expression.

Huang H, Li F, Gordon JR, Xiang J. Huang H, et al. Among authors: xiang j. Cancer Res. 2002 Apr 1;62(7):2043-51. Cancer Res. 2002. PMID: 11929823

5

Enhanced HER-2/neu-specific antitumor immunity by cotransduction of mouse dendritic cells with two genes encoding HER-2/neu and alpha tumor necrosis factor.

Chen Z, Huang H, Chang T, Carlsen S, Saxena A, Marr R, Xing Z, Xiang J. Chen Z, et al. Among authors: xiang j. Cancer Gene Ther. 2002 Sep;9(9):778-86. doi: 10.1038/sj.cgt.7700498. Cancer Gene Ther. 2002. PMID: 12189528

6

Engineered fusion hybrid vaccine of IL-4 gene-modified myeloma and relative mature dendritic cells enhances antitumor immunity.

Liu Y, Zhang W, Chan T, Saxena A, Xiang J. Liu Y, et al. Among authors: xiang j. Leuk Res. 2002 Aug;26(8):757-63. doi: 10.1016/s0145-2126(02)00002-4. Leuk Res. 2002. PMID: 12191571

7

DNA microarray analysis of the gene expression profiles of naïve versus activated tumor-specific T cells.

Zhang X, Chen Z, Huang H, Gordon JR, Xiang J. Zhang X, et al. Among authors: xiang j. Life Sci. 2002 Nov 8;71(25):3005-17. doi: 10.1016/s0024-3205(02)02164-1. Life Sci. 2002. PMID: 12384184

8

Synergistic effect of adoptive T-cell therapy and intratumoral interferon gamma-inducible protein-10 transgene expression in treatment of established tumors.

Huang H, Liu Y, Xiang J. Huang H, et al. Among authors: xiang j. Cell Immunol. 2002 May-Jun;217(1-2):12-22. doi: 10.1016/s0008-8749(02)00508-7. Cell Immunol. 2002. PMID: 12425997

9

Tumour necrosis factor-alpha (TNF-alpha) transgene-expressing dendritic cells (DCs) undergo augmented cellular maturation and induce more robust T-cell activation and anti-tumour immunity than DCs generated in recombinant TNF-alpha.

Zhang W, Chen Z, Li F, Kamencic H, Juurlink B, Gordon JR, Xiang J. Zhang W, et al. Among authors: xiang j. Immunology. 2003 Feb;108(2):177-88. doi: 10.1046/j.1365-2567.2003.01489.x. Immunology. 2003. PMID: 12562326 Free PMC article.

10

Dendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunity.

Liu Y, Huang H, Chen Z, Zong L, Xiang J. Liu Y, et al. Among authors: xiang j. J Gene Med. 2003 Aug;5(8):668-80. doi: 10.1002/jgm.387. J Gene Med. 2003. PMID: 12898636

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,321 results

Search Page

Filters